| scholarly article | Q13442814 |
| P2093 | author name string | Timothy R Geiger | |
| Jennifer M Martin | |||
| William F Coffin | |||
| P2860 | cites work | Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation | Q45759578 |
| High Concentration of the EBV Latent Membrane Protein 1 in Glycosphingolipid-Rich Complexes from both Epithelial and Lymphoid Cells | Q56917409 | ||
| Crystallographic analysis of CD40 recognition and signaling by human TRAF2 | Q24675068 | ||
| Structural basis for self-association and receptor recognition of human TRAF2 | Q27617947 | ||
| The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein | Q33180948 | ||
| The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells | Q33711057 | ||
| A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells | Q33756928 | ||
| Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins | Q33891012 | ||
| DNA sequence and expression of the B95-8 Epstein-Barr virus genome. | Q34245077 | ||
| Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. | Q34250209 | ||
| Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors | Q35291650 | ||
| Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus | Q35838888 | ||
| Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association | Q36695348 | ||
| The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels | Q36827992 | ||
| Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus | Q36861507 | ||
| An intricate route to immortality | Q38267805 | ||
| The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling | Q39589143 | ||
| Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression | Q39593467 | ||
| CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex | Q39645275 | ||
| LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling | Q39685776 | ||
| Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. | Q39879963 | ||
| Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent | Q40761285 | ||
| The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain | Q40782239 | ||
| The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation | Q40893186 | ||
| Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). | Q41044165 | ||
| A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated prot | Q41046589 | ||
| Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion | Q41098892 | ||
| The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover | Q41132484 | ||
| Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines | Q41172143 | ||
| Epstein-Barr virus: LMP1 masquerades as an active receptor | Q41725733 | ||
| Signal transduction from the Epstein-Barr virus LMP-1 transforming protein | Q45755742 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | membrane raft | Q424178 |
| transmembrane protein | Q424204 | ||
| Epstein–Barr virus | Q6900 | ||
| membrane protein | Q423042 | ||
| P304 | page(s) | 3749-3758 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis | |
| P478 | volume | 77 |
| Q40117245 | A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1. |
| Q40591623 | A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways |
| Q39939099 | Association of dengue virus NS1 protein with lipid rafts |
| Q33649035 | Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats |
| Q24537608 | BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway |
| Q37307520 | Cross-regulation between herpesviruses and the TNF superfamily members |
| Q34270437 | Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells |
| Q35634286 | Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity |
| Q37587096 | High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association |
| Q40595025 | High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells |
| Q43125086 | Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. |
| Q34092709 | In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. |
| Q40629419 | Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation. |
| Q35052575 | LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation |
| Q35139273 | LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB |
| Q39777437 | LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments |
| Q35122447 | Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling |
| Q36659985 | Lipid rafts, detergent-resistant membranes, and raft targeting signals |
| Q35375389 | Multi-Tox: application of the ToxR-transcriptional reporter assay to the study of multi-pass protein transmembrane domain oligomerization |
| Q39605257 | Multiple cytosolic and transmembrane determinants are required for the trafficking of SCAMP1 via an ER-Golgi-TGN-PM pathway |
| Q24300115 | PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1 |
| Q34917410 | Reovirus FAST protein transmembrane domains function in a modular, primary sequence-independent manner to mediate cell-cell membrane fusion. |
| Q40323227 | TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB. |
| Q27318720 | Targeting of pseudorabies virus structural proteins to axons requires association of the viral Us9 protein with lipid rafts |
| Q40305675 | The Epstein-Barr virus oncoprotein LMP1 inhibits the activity of viral or cellular promoters without inducing cytostasis |
| Q39321358 | The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells |
| Q38597238 | The Latent Membrane Protein 1 (LMP1). |
| Q57169059 | Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1 |
| Q35333205 | Transmembrane peptides used to investigate the homo-oligomeric interface and binding hotspot of latent membrane protein 1. |
Search more.